spacer
spacer

PDBsum entry 1vap

Go to PDB code: 
protein links
Lipid degradation PDB id
1vap

 

 

 

 

Loading ...

 
JSmol PyMol  
Contents
Protein chains
123 a.a. *
Waters ×139
* Residue conservation analysis
PDB id:
1vap
Name: Lipid degradation
Title: The monomeric asp49 secretory phospholipase a2 from the venom of agkistridon piscivorus piscivorus
Structure: Phospholipase a2. Chain: a, b. Other_details: secretory phospholipase a2
Source: Agkistrodon piscivorus piscivorus. Eastern cottonmouth. Organism_taxid: 8716. Strain: piscivorus
Resolution:
1.60Å     R-factor:   0.197    
Authors: D.L.Scott
Key ref:
S.K.Han et al. (1997). Structural aspects of interfacial adsorption. A crystallographic and site-directed mutagenesis study of the phospholipase A2 from the venom of Agkistrodon piscivorus piscivorus. J Biol Chem, 272, 3573-3582. PubMed id: 9013608 DOI: 10.1074/jbc.272.26.16152
Date:
15-Nov-96     Release date:   07-Jul-97    
PROCHECK
Go to PROCHECK summary
 Headers
 References

Protein chains
Pfam   ArchSchema ?
P51972  (PA2B1_AGKPI) -  Basic phospholipase A2 APP-D49 from Agkistrodon piscivorus piscivorus
Seq:
Struc:
123 a.a.
123 a.a.
Key:    PfamA domain  Secondary structure  CATH domain

 Enzyme reactions 
   Enzyme class: E.C.3.1.1.4  - phospholipase A2.
[IntEnz]   [ExPASy]   [KEGG]   [BRENDA]
      Reaction: a 1,2-diacyl-sn-glycero-3-phosphocholine + H2O = a 1-acyl-sn-glycero-3- phosphocholine + a fatty acid + H+
1,2-diacyl-sn-glycero-3-phosphocholine
+ H2O
= 1-acyl-sn-glycero-3- phosphocholine
+ fatty acid
+ H(+)
      Cofactor: Ca(2+)
Molecule diagrams generated from .mol files obtained from the KEGG ftp site

 

 
    reference    
 
 
DOI no: 10.1074/jbc.272.26.16152 J Biol Chem 272:3573-3582 (1997)
PubMed id: 9013608  
 
 
Structural aspects of interfacial adsorption. A crystallographic and site-directed mutagenesis study of the phospholipase A2 from the venom of Agkistrodon piscivorus piscivorus.
S.K.Han, E.T.Yoon, D.L.Scott, P.B.Sigler, W.Cho.
 
  ABSTRACT  
 
Recent genetic and structural studies have shed considerable light on the mechanism by which secretory phospholipases A2 interact with substrate aggregates. Electrostatic forces play an essential role in optimizing interfacial catalysis. Efficient and productive adsorption of the Class I bovine pancreatic phospholipase A2 to anionic interfaces is dependent upon the presence of two nonconserved lysine residues at sequence positions 56 and 116, implying that critical components of the adsorption surface differ among enzyme species (Dua, R., Wu, S.-K., and Cho, W. (1995) J. Biol. Chem. 270, 263-268). In an effort to further characterize the protein residues involved in interfacial catalysis, we have determined the high resolution (1.7 A) x-ray structure of the Class II Asp-49 phospholipase A2 from the venom of Agkistrodon piscivorus piscivorus. Correlation of the three-dimensional coordinates with kinetic data derived from site-directed mutations near the amino terminus (E6R, K7E, K10E, K11E, and K16E) and the active site (K54E and K69Y) defines much of the interface topography. Lysine residues at sequence positions 7 and 10 mediate the adsorption of A. p. piscivorus phospholipase A2 to anionic interfaces but play little role in the enzyme's interaction with electrically neutral surfaces or in substrate binding. Compared to the native enzyme, the mutant proteins K7E and K10E demonstrate comparable (20-fold) decreases in affinity and catalysis on polymerized mixed liposomes of 1-hexadecanoyl-2-(1-pyrenedecanoyl)-sn-glycero-3-phosphocholine and 1,2-bis[12-(lipoyloxy)dodecanoyl]-sn-glycero-3-phosphoglycerol, while the double mutant, K7E/K10E, shows a more dramatic 500-fold decrease in catalysis and interfacial adsorption. The calculated contributions of Lys-7 and Lys-10 to the free energy of binding of A. p. piscivorus phospholipase A2 to anionic liposomes (-1.8 kcal/mol at 25 degrees C per lysine) are additive (i.e. -3.7 kcal/mol) and together represent nearly half of the total binding energy. Although both lysine side chains lie exposed at the edge of the proposed interfacial adsorption surface, they are geographically remote from the corresponding interfacial determinants for the bovine enzyme. Our results confirm that interfacial adsorption is largely driven by electrostatic forces and demonstrate that the arrangement of the critical charges (e.g. lysines) is species-specific. This variability in the topography of the adsorption surface suggests a corresponding flexibility in the orientation of the active enzyme at the substrate interface.
 
  Selected figure(s)  
 
Figure 2.
Fig. 2. A stereoview of the -carbon trace of the crystalline App-D49 indicating the positions of mutated residues. The view of the enzyme shown here is similar to that used in previous publications to illustrate the location of a co-crystallized transition-state^ analog (9, 17, 28). The active site lies at the base of^ the central cavity formed from the amino-terminal helix, residues 19-23, portions of the calcium-binding loop, and the side chain of Lys-69 and is indicated by the side chain of His-48 (in black). The plane of the putative interfacial adsorption surface lies perpendicular to the hydrophobic channel and incorporates residues surrounding the external opening of the channel. In the present study, specific lysine residues (Lys-7, Lys-10, Lys-11, Lys-16, Lys-54, and Lys-69) were changed into glutamates and tyrosine^ (Lys-69) in an effort to characterize the structural determinants of interfacial adsorption.
Figure 5.
Fig. 5. The interaction of a transition-state analog (L-1-O-octyl-2-heptylphosphonyl-sn-glycero-3-phosphoethanolamine) with the^ active site of the Class I PLA[2] from the venom of N. n. atra (A). Class II PLA[2]s, including App-D49, substitute a lysine residue^ for the tyrosine at sequence position 69. The K69Y mutant has essentially the same activity as the wild type enzyme toward PC^ and PE substrates but shows a 3-fold drop in activity toward PG substrate. One explanation for this finding is that the -ammonium group of Lys-69 forms additional hydrogen bonds with phospholipid^ head groups, especially with PG whose hydroxyl groups can function as hydrogen bond acceptors (B). Such an interaction would not be achievable by the phenolic oxygen of Tyr-69 or with PC and^ PE as substrate.
 
  The above figures are reprinted by permission from the ASBMB: J Biol Chem (1997, 272, 3573-3582) copyright 1997.  
  Figures were selected by an automated process.  

Literature references that cite this PDB file's key reference

  PubMed id Reference
19379723 K.Kadoshima-Yamaoka, M.Goto, M.Murakawa, R.Yoshioka, Y.Tanaka, H.Inoue, H.Murafuji, S.Kanki, Y.Hayashi, K.Nagahira, A.Ogata, T.Nakatsuka, and Y.Fukuda (2009).
ASB16165, a phosphodiesterase 7A inhibitor, reduces cutaneous TNF-alpha level and ameliorates skin edema in phorbol ester 12-O-tetradecanoylphorbol-13-acetate-induced skin inflammation model in mice.
  Eur J Pharmacol, 613, 163-166.  
18405237 G.Lambeau, and M.H.Gelb (2008).
Biochemistry and physiology of mammalian secreted phospholipases A2.
  Annu Rev Biochem, 77, 495-520.  
17827229 L.Linderoth, T.L.Andresen, K.Jørgensen, R.Madsen, and G.H.Peters (2008).
Molecular basis of phospholipase A2 activity toward phospholipids with sn-1 substitutions.
  Biophys J, 94, 14-26.  
17952431 R.Malik, R.S.Bora, D.Gupta, P.Sharma, R.Arya, S.Chaudhary, and K.S.Saini (2008).
Cloning, stable expression of human phosphodiesterase 7A and development of an assay for screening of PDE7 selective inhibitors.
  Appl Microbiol Biotechnol, 77, 1167-1173.  
18062812 G.Faure, V.T.Gowda, and R.C.Maroun (2007).
Characterization of human coagulation factor Xa-binding site on Viperidae snake venom phospholipases A2 by affinity binding studies and molecular bioinformatics.
  BMC Struct Biol, 7, 82.  
17257185 J.N.Fleming-Waddell, L.M.Wilson, G.R.Olbricht, T.Vuocolo, K.Byrne, B.A.Craig, R.L.Tellam, N.E.Cockett, and C.A.Bidwell (2007).
Analysis of gene expression during the onset of muscle hypertrophy in callipyge lambs.
  Anim Genet, 38, 28-36.  
17922623 L.Vijayakrishnan, S.Rudra, M.S.Eapen, S.Dastidar, and A.Ray (2007).
Small-molecule inhibitors of PDE-IV and -VII in the treatment of respiratory diseases and chronic inflammation.
  Expert Opin Investig Drugs, 16, 1585-1599.  
16461407 C.Leidy, L.Linderoth, T.L.Andresen, O.G.Mouritsen, K.Jørgensen, and G.H.Peters (2006).
Domain-induced activation of human phospholipase A2 type IIA: local versus global lipid composition.
  Biophys J, 90, 3165-3175.  
16102838 C.Lugnier (2006).
Cyclic nucleotide phosphodiesterase (PDE) superfamily: a new target for the development of specific therapeutic agents.
  Pharmacol Ther, 109, 366-398.  
16815627 S.Uckert, P.Hedlund, K.E.Andersson, M.C.Truss, U.Jonas, and C.G.Stief (2006).
Update on phosphodiesterase (PDE) isoenzymes as pharmacologic targets in urology: present and future.
  Eur Urol, 50, 1194.  
16331503 S.Uckert, C.G.Stief, M.Mayer, U.Jonas, and P.Hedlund (2005).
Distribution and functional significance of phosphodiesterase isoenzymes in the human lower urinary tract.
  World J Urol, 23, 368-373.  
15748655 T.L.Andresen, S.S.Jensen, and K.Jørgensen (2005).
Advanced strategies in liposomal cancer therapy: problems and prospects of active and tumor specific drug release.
  Prog Lipid Res, 44, 68-97.  
14501106 M.Perbandt, I.H.Tsai, A.Fuchs, S.Banumathi, K.R.Rajashankar, D.Georgieva, N.Kalkura, T.P.Singh, N.Genov, and C.Betzel (2003).
Structure of the heterodimeric neurotoxic complex viperotoxin F (RV-4/RV-7) from the venom of Vipera russelli formosensis at 1.9 A resolution.
  Acta Crystallogr D Biol Crystallogr, 59, 1679-1687.
PDB code: 1oqs
12609879 S.A.Tatulian (2003).
Structural effects of covalent inhibition of phospholipase A2 suggest allosteric coupling between membrane binding and catalytic sites.
  Biophys J, 84, 1773-1783.  
11389606 A.H.de Oliveira, J.R.Giglio, S.H.Andrião-Escarso, A.S.Ito, and R.J.Ward (2001).
A pH-induced dissociation of the dimeric form of a lysine 49-phospholipase A2 abolishes Ca2+-independent membrane damaging activity.
  Biochemistry, 40, 6912-6920.  
11258945 B.Lathrop, M.Gadd, R.L.Biltonen, and G.S.Rule (2001).
Changes in Ca2+ affinity upon activation of Agkistrodon piscivorus piscivorus phospholipase A2.
  Biochemistry, 40, 3264-3272.  
11502204 K.Yuasa, T.Ohgaru, M.Asahina, and K.Omori (2001).
Identification of rat cyclic nucleotide phosphodiesterase 11A (PDE11A): comparison of rat and human PDE11A splicing variants.
  Eur J Biochem, 268, 4440-4448.  
11159426 M.T.Hyvönen, K.Oörni, P.T.Kovanen, and M.Ala-Korpela (2001).
Changes in a phospholipid bilayer induced by the hydrolysis of a phospholipase A2 enzyme: a molecular dynamics simulation study.
  Biophys J, 80, 565-578.  
11294634 R.V.Stahelin, and W.Cho (2001).
Differential roles of ionic, aliphatic, and aromatic residues in membrane-protein interactions: a surface plasmon resonance study on phospholipases A2.
  Biochemistry, 40, 4672-4678.  
11159446 S.A.Tatulian (2001).
Toward understanding interfacial activation of secretory phospholipase A2 (PLA2): membrane surface properties and membrane-induced structural changes in the enzyme contribute synergistically to PLA2 activation.
  Biophys J, 80, 789-800.  
11141053 W.H.Lee, M.T.da Silva Giotto, S.Marangoni, M.H.Toyama, I.Polikarpov, and R.C.Garratt (2001).
Structural basis for low catalytic activity in Lys49 phospholipases A2--a hypothesis: the crystal structure of piratoxin II complexed to fatty acid.
  Biochemistry, 40, 28-36.
PDB code: 1qll
10673441 A.Dessen (2000).
Phospholipase A(2) enzymes: structural diversity in lipid messenger metabolism.
  Structure, 8, R15-R22.  
10679892 M.Falconi, A.Desideri, and S.Rufini (2000).
Membrane-perturbing activity of Viperidae myotoxins: an electrostatic surface potential approach to a puzzling problem.
  J Mol Recognit, 13, 14-19.  
11201998 N.Iijima, S.Uchiyama, Y.Fujikawa, and M.Esaka (2000).
Purification, characterization, and molecular cloning of group I phospholipases A2 from the gills of the red sea bream, Pagrus major.
  Lipids, 35, 1359-1370.  
10387021 B.I.Lee, R.Dua, and W.Cho (1999).
A structural determinant of the unique interfacial binding mode of bovine pancreatic phospholipase A2.
  Biochemistry, 38, 7811-7818.  
10339439 F.Reichsman, H.M.Moore, and S.Cumberledge (1999).
Sequence homology between Wingless/Wnt-1 and a lipid-binding domain in secreted phospholipase A2.
  Curr Biol, 9, R353-R355.  
10411650 J.Kotera, K.Fujishige, Y.Imai, E.Kawai, H.Michibata, H.Akatsuka, N.Yanaka, and K.Omori (1999).
Genomic origin and transcriptional regulation of two variants of cGMP-binding cGMP-specific phosphodiesterases.
  Eur J Biochem, 262, 866-873.  
10583409 K.Fujishige, J.Kotera, and K.Omori (1999).
Striatum- and testis-specific phosphodiesterase PDE10A isolation and characterization of a rat PDE10A.
  Eur J Biochem, 266, 1118-1127.  
10487537 M.Ahlström, and C.Lamberg-Allardt (1999).
Regulation of adenosine 3',5'-cyclic monophosphate (cAMP) accumulation in UMR-106 osteoblast-like cells: role of cAMP-phosphodiesterase and cAMP efflux.
  Biochem Pharmacol, 58, 1335-1340.  
10449366 M.H.Gelb, W.Cho, and D.C.Wilton (1999).
Interfacial binding of secreted phospholipases A(2): more than electrostatics and a major role for tryptophan.
  Curr Opin Struct Biol, 9, 428-432.  
10477825 M.J.Janssen, L.Vermeulen, H.A.Van der Helm, A.J.Aarsman, A.J.Slotboom, and M.R.Egmond (1999).
Enzymatic properties of rat group IIA and V phospholipases A(2) compared.
  Biochim Biophys Acta, 1440, 59-72.  
10587453 M.Sumandea, S.Das, C.Sumandea, and W.Cho (1999).
Roles of aromatic residues in high interfacial activity of Naja naja atra phospholipase A2.
  Biochemistry, 38, 16290-16297.  
9893113 T.P.Dousa (1999).
Cyclic-3',5'-nucleotide phosphodiesterase isozymes in cell biology and pathophysiology of the kidney.
  Kidney Int, 55, 29-62.  
10387020 Y.Snitko, S.K.Han, B.I.Lee, and W.Cho (1999).
Differential interfacial and substrate binding modes of mammalian pancreatic phospholipases A2: a comparison among human, bovine, and porcine enzymes.
  Biochemistry, 38, 7803-7810.  
9578553 F.Ghomashchi, Y.Lin, M.S.Hixon, B.Z.Yu, R.Annand, M.K.Jain, and M.H.Gelb (1998).
Interfacial recognition by bee venom phospholipase A2: insights into nonelectrostatic molecular determinants by charge reversal mutagenesis.
  Biochemistry, 37, 6697-6710.  
9692961 J.B.Henshaw, C.A.Olsen, A.R.Farnbach, K.H.Nielson, and J.D.Bell (1998).
Definition of the specific roles of lysolecithin and palmitic acid in altering the susceptibility of dipalmitoylphosphatidylcholine bilayers to phospholipase A2.
  Biochemistry, 37, 10709-10721.  
9760249 L.Lichtenbergova, E.T.Yoon, and W.Cho (1998).
Membrane penetration of cytosolic phospholipase A2 is necessary for its interfacial catalysis and arachidonate specificity.
  Biochemistry, 37, 14128-14136.  
9736920 M.J.Perry, and G.A.Higgs (1998).
Chemotherapeutic potential of phosphodiesterase inhibitors.
  Curr Opin Chem Biol, 2, 472-481.  
The most recent references are shown first. Citation data come partly from CiteXplore and partly from an automated harvesting procedure. Note that this is likely to be only a partial list as not all journals are covered by either method. However, we are continually building up the citation data so more and more references will be included with time. Where a reference describes a PDB structure, the PDB code is shown on the right.

 

spacer

spacer